Citations (102)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Musa Alzahrani, Ibrahim Alrumaih, Fahad Alhamad & Ahmed Abdel Warith. (2018) Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature. Platelets 29:6, pages 628-631.
Read now
Read now
Yoshiro Hayashi, Jason A Roberts, David L Paterson & Jeffrey Lipman. (2010) Pharmacokinetic evaluation of piperacillin-tazobactam. Expert Opinion on Drug Metabolism & Toxicology 6:8, pages 1017-1031.
Read now
Read now
Alexandre P Zavascki, Cecília G Carvalhaes, Renata C Picão & Ana C Gales. (2010) Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Review of Anti-infective Therapy 8:1, pages 71-93.
Read now
Read now
Maria F Wolf & Arne Simon. (2009) The use of piperacillin–tazobactam in neonatal and paediatric patients. Expert Opinion on Drug Metabolism & Toxicology 5:1, pages 57-69.
Read now
Read now
Articles from other publishers (98)
Raul Velez-Montoya, Luz Monroy-Esquivel, Rocío Ortiz-Guevara, Hugo Quiroz-Mercado & Jans Fromow-Guerra. (2023) ALTERNATIVE INTRAVITREAL ANTIBIOTICS. Retina 43:9, pages 1433-1447.
Crossref
Crossref
Satish Bhavsar, Sanjeev Joshi, Shivaji Pawar, Laxmikant Pavase, Amit Mishra, Sunil Jadhav, Sanjay Dabhade, Abhijeet K. Kayastha, Ravindra Yeole, Prasad Deshpande, Sachin Bhagwat & Mahesh Patel. (2023) Structure activity relationship (SAR) driven design and discovery of WCK 5107 (Zidebactam): novel β-lactam enhancer, potent against multidrug-resistant gram-negative pathogens. Medicinal Chemistry Research.
Crossref
Crossref
Yang Sun, Yu Liu, Jixia Wang & Can Cui. (2023) The effect of meropenem versus piperacillin-tazobactam in critically ill patients with sepsis and septic shock. Heliyon 9:6, pages e16542.
Crossref
Crossref
Johanne Gade Lilleøre, Andrea René Jørgensen, Martin Bruun Knudsen, Pelle Hanberg, Kristina Öbrink-Hansen, Sara Kousgaard Tøstesen, Kjeld Søballe, Maiken Stilling & Mats Bue. (2023) Steady-State Piperacillin Concentrations in the Proximity of an Orthopedic Implant: A Microdialysis Porcine Study. Antibiotics 12:3, pages 615.
Crossref
Crossref
Lekshmi Narendrakumar, Medha Chakraborty, Shashi Kumari, Deepjyoti Paul & Bhabatosh Das. (2023) β-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward. Frontiers in Microbiology 13.
Crossref
Crossref
Kaushita Banerjee & Harishkumar Madhyastha. 2023. Current Trends in the Identification and Development of Antimicrobial Agents. Current Trends in the Identification and Development of Antimicrobial Agents
304
338
.
Debabrata Dash & Sumit Rai. (2023) Clinical implications of revised piperacillin-tazobactam breakpoints in CLSI M-100 S32. Indian Journal of Medical Microbiology 42, pages 108-109.
Crossref
Crossref
Lalit Gupta, KirtiNath Saxena & Ruchi Goyal. (2023) Antibiotic challenges and review of appropriate uses in intensive care unit. Journal of Indian College of Anaesthesiologists 2:1, pages 7.
Crossref
Crossref
Vasiliy M. Muzalevskiy, Zoia A. Sizova, Mikhail S. Nechaev & Valentine G. Nenajdenko. (2022) Acid-Switchable Synthesis of Trifluoromethylated Triazoles and Isoxazoles via Reaction of CF3-Ynones with NaN3: DFT Study of the Reaction Mechanism. International Journal of Molecular Sciences 23:23, pages 14522.
Crossref
Crossref
Elisabeth Krogsgaard Petersen, Pelle Hanberg, Martin Knudsen, Sara Kousgaard Tøstesen, Andrea René Jørgensen, Kristina Öbrink-Hansen, Kjeld Søballe, Maiken Stilling & Mats Bue. (2022) Intermittent Short-Term Infusion vs. Continuous Infusion of Piperacillin: Steady State Concentrations in Porcine Cervical Spine Tissue Evaluated by Microdialysis. Antibiotics 11:7, pages 910.
Crossref
Crossref
Ferdinand Anton Weinelt, Miriam Songa Stegemann, Anja Theloe, Frieder Pfäfflin, Stephan Achterberg, Franz Weber, Lucas Dübel, Agata Mikolajewska, Alexander Uhrig, Peggy Kiessling, Wilhelm Huisinga, Robin Michelet, Stefanie Hennig & Charlotte Kloft. (2022) Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools. Antibiotics 11:6, pages 758.
Crossref
Crossref
Thomas Edwards, Eva Heinz, Jon van Aartsen, Alex Howard, Paul Roberts, Caroline Corless, Alice J. Fraser, Christopher T. Williams, Issra Bulgasim, Luis E. Cuevas, Christopher M. Parry, Adam P. Roberts, Emily R. Adams, Jenifer Mason & Alasdair T. M. Hubbard. (2022) Piperacillin/tazobactam-resistant, cephalosporin-susceptible Escherichia coli bloodstream infections are driven by multiple acquisition of resistance across diverse sequence types. Microbial Genomics 8:4.
Crossref
Crossref
Jiawen Lv, Guannan Wu, Fang Zhang & Xin Su. (2022) An unusual case of piperacillin-tazobactam-induced fever, eosinophilia, thrombocytopenia and liver damage. European Journal of Hospital Pharmacy 29:e1, pages e91-e94.
Crossref
Crossref
Hongwei Wang, Yongquan Ning, Paramasivam Sivaguru, Giuseppe Zanoni & Xihe Bi. (2022) [4 + 1] Annulation of in situ generated azoalkenes with amines: A powerful approach to access 1-substituted 1,2,3-triazoles. Chinese Chemical Letters 33:3, pages 1550-1554.
Crossref
Crossref
Sachin M. Patil & Parag Patel. 2021. Infections and Sepsis Development. Infections and Sepsis Development.
Martin Knudsen, Mats Bue, Louise L. Pontoppidan, Magnus A. Hvistendahl, Kjeld Søballe, Maiken Stilling & Pelle Hanberg. (2021) Evaluation of Benzylpenicillin as an Internal Standard for Measurement of Piperacillin Bone Concentrations Via Microdialysis. Journal of Pharmaceutical Sciences 110:10, pages 3500-3506.
Crossref
Crossref
Sarah Van Vooren, Jan J. De Waele, Jerina Boelens, Michael Polet, Veronique Stove, Lynn Vanhaecke & Alain G. Verstraete. (2021) Development and validation of a liquid chromatography high-resolution mass spectrometry orbitrap method for the sensitive quantification of amoxicillin, piperacillin, tazobactam and meropenem in human faeces. Analytica Chimica Acta 1177, pages 338760.
Crossref
Crossref
David Busse, Philipp Simon, David Petroff, Christoph Dorn, Lisa Schmitt, Davide Bindellini, Alexander Kratzer, Arne Dietrich, Markus Zeitlinger, Wilhelm Huisinga, Robin Michelet, Hermann Wrigge & Charlotte Kloft. (2021) Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics. Pharmaceutics 13:9, pages 1380.
Crossref
Crossref
Donald J. AbrahamSebastian A. Testero, Leticia I. Llarrull, Jed F. Fisher & Shahriar Mobashery. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
188
.
Jianjing Yang, Zongzhao Sun, Kelu Yan, Haozhe Dong, Hongyan Dong, Jiakai Cui, Xutao Gong, Shilin Han, Limin Huang & Jiangwei Wen. (2021) Single-atom-nickel photocatalytic site-selective sulfonation of enamides to access amidosulfones. Green Chemistry 23:7, pages 2756-2762.
Crossref
Crossref
Vicente Merino-Bohórquez, Fernando Docobo-Pérez, Adoración Valiente-Méndez, Mercedes Delgado-Valverde, Manuel Cameán, William W. Hope, Álvaro Pascual & Jesús Rodríguez-Baño. (2021) Population Pharmacokinetics of Piperacillin in Non-Critically Ill Patients with Bacteremia Caused by Enterobacteriaceae. Antibiotics 10:4, pages 348.
Crossref
Crossref
Thomas Maitre, Vichita Ok, Ruxandra Calin, Ludovic Lassel, Ana Canestri, Michel Denis, Mohammed Hamidi, Sebastian Tavolaro, Charlotte Verdet, Antoine Parrot, Jacques Cadranel & Gilles Pialoux. (2021) Pyogenic lung abscess in an infectious disease unit: a 20-year retrospective study. Therapeutic Advances in Respiratory Disease 15, pages 175346662110030.
Crossref
Crossref
Takeshi Fujita, Masafumi Takeishi & Junji Ichikawa. (2020) Copper-Catalyzed [3 + 2] Annulation of Azides with a (Difluorovinyl)zinc Complex, Fluoroacetylene Equivalent. Organic Letters 22:23, pages 9253-9257.
Crossref
Crossref
Jason Kim, Jenny Zhang, Yoonjeong Cha, Sarah Kolitz, Jason Funt, Renan Escalante Chong, Scott Barrett, Rebecca Kusko, Ben Zeskind & Howard Kaufman. (2020) Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19). Journal of Translational Medicine 18:1.
Crossref
Crossref
Tafese Beyene Tufa, Andre Fuchs, Torsten Feldt, Desalegn Tadesse Galata, Colin R. Mackenzie, Klaus Pfeffer & Dieter Häussinger. (2020) CTX-M-9 group ESBL-producing Raoultella planticola nosocomial infection: first report from sub-Saharan Africa. Annals of Clinical Microbiology and Antimicrobials 19:1.
Crossref
Crossref
Emma McLaren, Iouri Banakh, Sok Leng Cam, Grace Loh, Darshana Meanger & Lakmal Wanniarachchi. (2020) Acute kidney injury risk with piperacillin‐tazobactam and vancomycin combination therapy: single centre retrospective study. Journal of Pharmacy Practice and Research 50:6, pages 514-518.
Crossref
Crossref
Corneliu Ovidiu Vrancianu, Irina Gheorghe, Elena-Georgiana Dobre, Ilda Czobor Barbu, Roxana Elena Cristian, Marcela Popa, Sang Hee Lee, Carmen Limban, Ilinca Margareta Vlad & Mariana Carmen Chifiriuc. (2020) Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens. International Journal of Molecular Sciences 21:22, pages 8527.
Crossref
Crossref
Shivakumar S. Jalde & Hyun Kyung Choi. (2020) Recent advances in the development of β-lactamase inhibitors. Journal of Microbiology 58:8, pages 633-647.
Crossref
Crossref
Mai Alalawi, Seba Aljahdali, Bashaer Alharbi, Lana Fagih, Raghad Fatani & Ohoud Aljuhani. (2020)
Clostridium difficile
infection in an academic medical center in Saudi Arabia: prevalence and risk factors
. Annals of Saudi Medicine 40:4, pages 305-309.
Crossref
Crossref
Vibeke Klastrup, Anders Thorsted, Merete Storgaard, Steffen Christensen, Lena E. Friberg & Kristina Öbrink-Hansen. (2020) Population Pharmacokinetics of Piperacillin following Continuous Infusion in Critically Ill Patients and Impact of Renal Function on Target Attainment. Antimicrobial Agents and Chemotherapy 64:7.
Crossref
Crossref
Yu Xie, Guoming Huang, Yujun Wang, Zhengren Yan, Xin Wang, Juan Huang, Mingtang Gao, Weiyang Fei & Guangsheng Luo. (2020) Synthesis of piperacillin with low impurity content using a new three-feed membrane dispersion microreactor. Chemical Engineering Journal 387, pages 124178.
Crossref
Crossref
Dor Russ, Fabian Glaser, Einat Shaer Tamar, Idan Yelin, Michael Baym, Eric D. Kelsic, Claudia Zampaloni, Andreas Haldimann & Roy Kishony. (2020) Escape mutations circumvent a tradeoff between resistance to a beta-lactam and resistance to a beta-lactamase inhibitor. Nature Communications 11:1.
Crossref
Crossref
Sean AinsworthSean Ainsworth. 2020. Neonatal Formulary. Neonatal Formulary
589
675
.
Wenchao Ye, Chuanfa Ni & Jinbo Hu. (2020) Stereoselective nucleophilic monofluoromethylation of tert-butanesulfinimines: Dynamic thermodynamic Resolution of racemic α-fluoro carbanions. Journal of Fluorine Chemistry 231, pages 109451.
Crossref
Crossref
Tiziana Ciarambino, Orazio Valerio Giannico, Amalia Campanile, Paolo Tirelli, Ombretta Para, Giuseppe Signoriello & Mauro Giordano. (2020) Acute kidney injury and vancomycin/piperacillin/tazobactam in adult patients: a systematic review. Internal and Emergency Medicine 15:2, pages 327-331.
Crossref
Crossref
M.V.K.S. Wickramanayake, P.S. Dahanayake, Sabrina Hossain & Gang‐Joon Heo. (2019)
Antimicrobial resistance of pathogenic
Aeromonas
spp. isolated from marketed Pacific abalone (
Haliotis discus hannai
) in Korea
. Journal of Applied Microbiology 128:2, pages 606-617.
Crossref
Crossref
Marie‐Claire Giel, Christopher J. Smedley, Emily R. R. Mackie, Taijie Guo, Jiajia Dong, Tatiana P. Soares da Costa & John E. Moses. (2019) Metal‐Free Synthesis of Functional 1‐Substituted‐1,2,3‐Triazoles from Ethenesulfonyl Fluoride and Organic Azides. Angewandte Chemie International Edition 59:3, pages 1181-1186.
Crossref
Crossref
Marie‐Claire Giel, Christopher J. Smedley, Emily R. R. Mackie, Taijie Guo, Jiajia Dong, Tatiana P. Soares da Costa & John E. Moses. (2019) Metal‐Free Synthesis of Functional 1‐Substituted‐1,2,3‐Triazoles from Ethenesulfonyl Fluoride and Organic Azides. Angewandte Chemie 132:3, pages 1197-1202.
Crossref
Crossref
Cheng-Chun Tai, Ruey-Yi Chou, Jiun-Yu Guo & Hsin-Pai Chen. (2020) Severe acute hypokalaemia associated with piperacillin/tazobactam in an HIV-infected patient under antiretroviral therapy with tenofovir alafenamide: case report and literature review. Sexual Health 17:2, pages 194.
Crossref
Crossref
Anders Thorsted, Anders N Kristoffersson, Sabine F Maarbjerg, Henrik Schrøder, Mikala Wang, Birgitte Brock, Elisabet I Nielsen & Lena E Friberg. (2019) Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen. Journal of Antimicrobial Chemotherapy 74:10, pages 2984-2993.
Crossref
Crossref
Angelo Viola, Lucia Ferrazzano, Giulia Martelli, Lucia Cerisoli, Antonio Ricci, Alessandra Tolomelli & Walter Cabri. (2019) Novel insights into the chemistry of an old medicine: A general degradative pathway for penicillins from a piperacillin/tazobactam stability study. European Journal of Pharmaceutical Sciences 136, pages 104957.
Crossref
Crossref
Sanjai Saxena, Manmohan Chhibber & Inder Pal Singh. (2019) Fungal Bioactive Compounds in Pharmaceutical Research and Development. Current Bioactive Compounds 15:2, pages 211-231.
Crossref
Crossref
Katharina Olbrisch, Tobias Kisch, Julia Thern, Evelyn Kramme, Jan Rupp, Tobias Graf, Sebastian G. Wicha, Peter Mailänder & Walter Raasch. (2018) After standard dosage of piperacillin plasma concentrations of drug are subtherapeutic in burn patients. Naunyn-Schmiedeberg's Archives of Pharmacology 392:2, pages 229-241.
Crossref
Crossref
Jorge Enrique Machado-Alba, Andres Gaviria-Mendoza & Manuel E. Machado-Duque. (2018) Results of the effectiveness of two piperacillin–tazobactam molecules in the real world. International Journal of Infectious Diseases 76, pages 91-96.
Crossref
Crossref
Sofie A.M. Dhaese, Magalie De Kezel, Maxime Callant, Jerina Boelens, Liesbet De Bus, Pieter Depuydt & Jan J. De Waele. (2018) Emergence of antimicrobial resistance to piperacillin/tazobactam or meropenem in the ICU: Intermittent versus continuous infusion. A retrospective cohort study. Journal of Critical Care 47, pages 164-168.
Crossref
Crossref
Maria Goul Andersen, Anders Thorsted, Merete Storgaard, Anders N. Kristoffersson, Lena E. Friberg & Kristina Öbrink-Hansen. (2018) Population Pharmacokinetics of Piperacillin in Sepsis Patients: Should Alternative Dosing Strategies Be Considered?. Antimicrobial Agents and Chemotherapy 62:5.
Crossref
Crossref
Brian Yu, Adedayo Adedoyin, Ellie Hershberger, Luzelena Caro, Alan Xiao, Elizabeth G. Rhee & Jennifer A. Huntington. (2018) Safety, Tolerability, and Pharmacokinetics of 3 g of Ceftolozane/Tazobactam in Healthy Adults: A Randomized, Placebo-Controlled, Multiple-Dose Study. Clinical Pharmacology in Drug Development 7:4, pages 382-391.
Crossref
Crossref
Saiyuri Naicker, Yarmarly C. Guerra Valero, Jenny L. Ordenez Meija, Jeffrey Lipman, Jason A. Roberts, Steven C. Wallis & Suzanne L. Parker. (2018) A UHPLC–MS/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluent. Journal of Pharmaceutical and Biomedical Analysis 148, pages 324-333.
Crossref
Crossref
Abdulaziz S. Alobaid, Steven C. Wallis, Paul Jarrett, Therese Starr, Janine Stuart, Melissa Lassig-Smith, Jenny Lisette Ordóñez Mejia, Michael S. Roberts, Claire Roger, Andrew A. Udy, Jeffrey Lipman & Jason A. Roberts. (2017) Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients. Antimicrobial Agents and Chemotherapy 61:3.
Crossref
Crossref
H. Bao, Y. Lv, D. Wang, J. Xue & Z. Yan. (2016) Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled trial. European Journal of Clinical Microbiology & Infectious Diseases 36:3, pages 459-466.
Crossref
Crossref
Yuko Saito, Susumu Ookawara, Hisataka Uchima, Takeshi Ishida, Masafumi Kakei & Hitoshi Sugawara. (2017) Anaphylactoid Purpura Associated with Streptococcal Cellulitis: A Case Report and Literature Review. Case Reports in Medicine 2017, pages 1-6.
Crossref
Crossref
Dawood Yusef, Blanca E. Gonzalez, Charles B. Foster, Johanna Goldfarb, Carla Saracusa, Sarah Worley & Camille Sabella. (2017) Piperacillin–Tazobactam-induced Adverse Drug Events in Pediatric Patients on Outpatient Parenteral Antimicrobial Therapy. Pediatric Infectious Disease Journal 36:1, pages 50-52.
Crossref
Crossref
Shibani Basu & Bimal K. Banik. 2017. Beta-Lactams. Beta-Lactams
285
309
.
Josef Yayan, Beniam Ghebremedhin & Kurt Rasche. (2016) Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis – an observational study. BMC Pharmacology and Toxicology 17:1.
Crossref
Crossref
Massimo Sartelli, Dieter G. Weber, Etienne Ruppé, Matteo Bassetti, Brian J. Wright, Luca Ansaloni, Fausto Catena, Federico Coccolini, Fikri M. Abu-Zidan, Raul Coimbra, Ernest E. Moore, Frederick A. Moore, Ronald V. Maier, Jan J. De Waele, Andrew W. Kirkpatrick, Ewen A. Griffiths, Christian Eckmann, Adrian J. Brink, John E. Mazuski, Addison K. May, Rob G. Sawyer, Dominik Mertz, Philippe Montravers, Anand Kumar, Jason A. Roberts, Jean-Louis Vincent, Richard R. Watkins, Warren Lowman, Brad Spellberg, Iain J. Abbott, Abdulrashid Kayode Adesunkanmi, Sara Al-Dahir, Majdi N. Al-Hasan, Ferdinando Agresta, Asma A. Althani, Shamshul Ansari, Rashid Ansumana, Goran Augustin, Miklosh Bala, Zsolt J. Balogh, Oussama Baraket, Aneel Bhangu, Marcelo A. Beltrán, Michael Bernhard, Walter L. Biffl, Marja A. Boermeester, Stephen M. Brecher, Jill R. Cherry-Bukowiec, Otmar R. Buyne, Miguel A. Cainzos, Kelly A. Cairns, Adrian Camacho-Ortiz, Sujith J. Chandy, Asri Che Jusoh, Alain Chichom-Mefire, Caroline Colijn, Francesco Corcione, Yunfeng Cui, Daniel Curcio, Samir Delibegovic, Zaza Demetrashvili, Belinda De Simone, Sameer Dhingra, José J. Diaz, Isidoro Di Carlo, Angel Dillip, Salomone Di Saverio, Michael P. Doyle, Gereltuya Dorj, Agron Dogjani, Hervé Dupont, Soumitra R. Eachempati, Mushira Abdulaziz Enani, Valery N. Egiev, Mutasim M. Elmangory, Paula Ferrada, Joseph R. Fitchett, Gustavo P. Fraga, Nathalie Guessennd, Helen Giamarellou, Wagih Ghnnam, George Gkiokas, Staphanie R. Goldberg, Carlos Augusto Gomes, Harumi Gomi, Manuel Guzmán-Blanco, Mainul Haque, Sonja Hansen, Andreas Hecker, Wolfgang R. Heizmann, Torsten Herzog, Adrien Montcho Hodonou, Suk-Kyung Hong, Reinhold Kafka-Ritsch, Lewis J. Kaplan, Garima Kapoor, Aleksandar Karamarkovic, Martin G. Kees, Jakub Kenig, Ronald Kiguba, Peter K. Kim, Yoram Kluger, Vladimir Khokha, Kaoru Koike, Kenneth Y. Y. Kok, Victory Kong, Matthew C. Knox, Kenji Inaba, Arda Isik, Katia Iskandar, Rao R. Ivatury, Maurizio Labbate, Francesco M. Labricciosa, Pierre-François Laterre, Rifat Latifi, Jae Gil Lee, Young Ran Lee, Marc Leone, Ari Leppaniemi, Yousheng Li, Stephen Y. Liang, Tonny Loho, Marc Maegele, Sydney Malama, Hany E. Marei, Ignacio Martin-Loeches, Sanjay Marwah, Amos Massele, Michael McFarlane, Renato Bessa Melo, Ionut Negoi, David P. Nicolau, Carl Erik Nord, Richard Ofori-Asenso, AbdelKarim H. Omari, Carlos A. Ordonez, Mouaqit Ouadii, Gerson Alves Pereira Júnior, Diego Piazza, Guntars Pupelis, Timothy Miles Rawson, Miran Rems, Sandro Rizoli, Claudio Rocha, Boris Sakakhushev, Miguel Sanchez-Garcia, Norio Sato, Helmut A. Segovia Lohse, Gabriele Sganga, Boonying Siribumrungwong, Vishal G. Shelat, Kjetil Soreide, Rodolfo Soto, Peep Talving, Jonathan V. Tilsed, Jean-Francois Timsit, Gabriel Trueba, Ngo Tat Trung, Jan Ulrych, Harry van Goor, Andras Vereczkei, Ravinder S. Vohra, Imtiaz Wani, Waldemar Uhl, Yonghong Xiao, Kuo-Ching Yuan, Sanoop K. Zachariah, Jean-Ralph Zahar, Tanya L. Zakrison, Antonio Corcione, Rita M. Melotti, Claudio Viscoli & Perluigi Viale. (2016) Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World Journal of Emergency Surgery 11:1.
Crossref
Crossref
J. Petersson, C. G. Giske & E. Eliasson. (2016) Standard dosing of piperacillin and meropenem fail to achieve adequate plasma concentrations in ICU patients. Acta Anaesthesiologica Scandinavica 60:10, pages 1425-1436.
Crossref
Crossref
Andrew B. Janowski, Marian G. Michaels, Judith M. Martin & Michael D. Green. (2016) Piperacillin-Tazobactam Usage at a Tertiary Pediatric Hospital: An Antimicrobial Stewardship Review. Journal of the Pediatric Infectious Diseases Society 5:3, pages 342-345.
Crossref
Crossref
Anthony M. Nicasio, Brian D. VanScoy, Rodrigo E. Mendes, Mariana Castanheira, Catharine C. Bulik, Olanrewaju O. Okusanya, Sujata M. Bhavnani, Alan Forrest, Ronald N. Jones, Lawrence V. Friedrich, Judith N. Steenbergen & Paul G. Ambrose. (2016)
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an
In Vitro
Infection Model
. Antimicrobial Agents and Chemotherapy 60:4, pages 2075-2080.
Crossref
Crossref
George G. Zhanel, Doris Cheung, Heather Adam, Sheryl Zelenitsky, Alyssa Golden, Frank Schweizer, Bala Gorityala, Philippe R. S. Lagacé-Wiens, Andrew Walkty, Alfred S. Gin, Daryl J. Hoban & James A. Karlowsky. (2016) Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent. Drugs 76:5, pages 567-588.
Crossref
Crossref
Yong Kyun Kim, Jin Ah Jung, Hyang-Ki ChoiIn-Gyu BaeWon Suk ChoiJian HurSung Joon JinShin-Woo KimKi Tae KwonSang-Rok LeeJae-Gook ShinSungmin Kiem. (2016) Population Pharmacokinetic Analysis of Piperacillin/Tazobactam in Korean Patients with Acute Infections . Infection & Chemotherapy 48:3, pages 209.
Crossref
Crossref
Murat DİZBAY, Hasan Selçuk ÖZGER, Ömer KARAŞAHİN & Emine Fusun KARAŞAHİN. (2016) Treatment efficacy and superinfection rates in complicated urinarytract infections treated with ertapenem or piperacillin tazobactam. TURKISH JOURNAL OF MEDICAL SCIENCES 46, pages 1760-1764.
Crossref
Crossref
Marlene Fredborg, Flemming S. Rosenvinge, Erik Spillum, Stine Kroghsbo, Mikala Wang & Teis E. Sondergaard. (2015) Automated image analysis for quantification of filamentous bacteria. BMC Microbiology 15:1.
Crossref
Crossref
Iqbal Aziz & Mohd Amin Mir. (2015) Clinical and economic impact of appropriate empirical antibiotic therapy in complicated intra-abdominal infections: A retrospective study. Current Medicine Research and Practice 5:6, pages 262-269.
Crossref
Crossref
Kristina Öbrink-Hansen, Rasmus Vestergaard Juul, Merete Storgaard, Marianne Kragh Thomsen, Tore Forsingdal Hardlei, Birgitte Brock, Mads Kreilgaard & Jakob Gjedsted. (2015) Population Pharmacokinetics of Piperacillin in the Early Phase of Septic Shock: Does Standard Dosing Result in Therapeutic Plasma Concentrations?. Antimicrobial Agents and Chemotherapy 59:11, pages 7018-7026.
Crossref
Crossref
Ikuo Kobayashi, Kazuro Ikawa, Kogenta Nakamura, Genya Nishikawa, Keishi Kajikawa, Takahiko Yoshizawa, Masahito Watanabe, Yoshiharu Kato, Kenji Zennami, Kent Kanao, Motoi Tobiume, Yoshiaki Yamada, Kenji Mitsui, Masahiro Narushima, Norifumi Morikawa & Makoto Sumitomo. (2015) Penetration of piperacillin–tazobactam into human prostate tissue and dosing considerations for prostatitis based on site-specific pharmacokinetics and pharmacodynamics. Journal of Infection and Chemotherapy 21:8, pages 575-580.
Crossref
Crossref
Santiago Grau, Virginia Lozano, Amparo Valladares, Rafael Cavanillas, Yang Xie & Gonzalo Nocea. (2015) Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis. Applied Health Economics and Health Policy 13:4, pages 369-379.
Crossref
Crossref
Neha Goel, Vishaal Bhambhwani & Basudeb Ghosh. (2015) Multidrug-resistant Pseudomonas aeruginosa endophthalmitis in a silicone oil-filled eye treated with piperacillin/tazobactam: report of a case and review of literature. International Ophthalmology 35:4, pages 599-602.
Crossref
Crossref
Eun Kyoung Chung, S. Christian Cheatham, Megan R. Fleming, Daniel P. Healy, Katherine M. Shea & Michael B. Kays. (2015) Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients. The Journal of Clinical Pharmacology 55:8, pages 899-908.
Crossref
Crossref
Yohei Doi & Henry F. Chambers. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
263
277.e3
.
Josef Yayan & Kurt Rasche. 2016. Respiratory Contagion. Respiratory Contagion
39
56
.
. 2014. Neonatal Formulary 7. Neonatal Formulary 7
57
553
.
D. Attivi & S. Gibaud. (2014) Continuous infusion of piperacillin/tazobactam in patients with severe infections: A possible pharmacokinetic optimisation?. Annales Pharmaceutiques Françaises 72:3, pages 146-151.
Crossref
Crossref
Julie M. Varghese, Paul Jarrett, Robert J. Boots, Carl M.J. Kirkpatrick, Jeffrey Lipman & Jason A. Roberts. (2014) Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration. International Journal of Antimicrobial Agents 43:4, pages 343-348.
Crossref
Crossref
Jennifer A. Pratt, Melisa K. Stricherz, Priya S. Verghese & Michael J. Burke. (2014) Suspected piperacillin-tazobactam induced nephrotoxicity in the pediatric oncology population. Pediatric Blood & Cancer 61:2, pages 366-368.
Crossref
Crossref
Mark S. Butler, Avril A. B. Robertson & Matthew A. Cooper. (2014) Natural product and natural product derived drugs in clinical trials. Nat. Prod. Rep. 31:11, pages 1612-1661.
Crossref
Crossref
Mark S Butler, Mark A Blaskovich & Matthew A Cooper. (2013) Antibiotics in the clinical pipeline in 2013. The Journal of Antibiotics 66:10, pages 571-591.
Crossref
Crossref
George G. Zhanel, Christopher D. Lawson, Heather Adam, Frank Schweizer, Sheryl Zelenitsky, Philippe R. S. Lagacé-Wiens, Andrew Denisuik, Ethan Rubinstein, Alfred S. Gin, Daryl J. Hoban, Joseph P. Lynch3rd3rd & James A. Karlowsky. (2013) Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination. Drugs 73:2, pages 159-177.
Crossref
Crossref
Matthew E. Falagas, Giannoula S. Tansarli, Kazuro Ikawa & Konstantinos Z. Vardakas. (2013) Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review and Meta-analysis. Clinical Infectious Diseases 56:2, pages 272-282.
Crossref
Crossref
S. Christian Cheatham, Megan R. Fleming, Daniel P. Healy, Christina E.K. Chung, Katherine M. Shea, Melissa L. Humphrey & Michael B. Kays. (2013) Steady-state pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese patients. International Journal of Antimicrobial Agents 41:1, pages 52-56.
Crossref
Crossref
P.N.A. Harris & J.K. Ferguson. (2012) Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?. International Journal of Antimicrobial Agents 40:4, pages 297-305.
Crossref
Crossref
G. G. Zhanel, C. Yachison, K. Nichol, H. Adam, A. M. Noreddin, D. J. Hoban & J. A. Karlowsky. (2012) Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model. Journal of Antimicrobial Chemotherapy 67:7, pages 1706-1711.
Crossref
Crossref
Zhiping Li, Qin Li, Yi Wang, Di Cao & Chao Chen. (2012) Determination of Free and Total Piperacillin–Tazobactam in Plasma by HPLC–MS–MS: An Adapted Method for Neonates. Chromatographia 75:9-10, pages 533-539.
Crossref
Crossref
Wieslawa Duszynska, Fabio Silvio Taccone, Marcin Switala, Magdalena Hurkacz, Beata Kowalska-Krochmal & Andrzej Kübler. (2012) Continuous infusion of piperacillin/tazobactam in ventilator-associated pneumonia: a pilot study on efficacy and costs. International Journal of Antimicrobial Agents 39:2, pages 153-158.
Crossref
Crossref
Jean Klastersky, Ahmad Awada, Mariane Paesmans & Mickael Aoun. (2011) Febrile neutropenia: A critical review of the initial management. Critical Reviews in Oncology/Hematology 78:3, pages 185-194.
Crossref
Crossref
Kelly C. Wade & Daniel K. BenjaminJr.Jr.. 2011. Infectious Diseases of the Fetus and Newborn. Infectious Diseases of the Fetus and Newborn
1160
1211
.
Michael PfallerKarin Thursky. 2010. Kucers' The Use of Antibiotics Sixth Edition. Kucers' The Use of Antibiotics Sixth Edition
238
254
.
Donald J. AbrahamSebastian A. Testero, Jed F. Fisher & Shahriar Mobashery. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
257
402
.
Yigong Ge, M. J. Whitehouse, Ian Friedland & George H. Talbot. (2010) Pharmacokinetics and Safety of CXA-101, a New Antipseudomonal Cephalosporin, in Healthy Adult Male and Female Subjects Receiving Single- and Multiple-Dose Intravenous Infusions. Antimicrobial Agents and Chemotherapy 54:8, pages 3427-3431.
Crossref
Crossref
Getahun Abate, Ketan Godbole & Christa Springston. (2010) Piperacillin/Tazobactam–Induced Petechial Rash. Annals of Pharmacotherapy 44:7-8, pages 1345-1346.
Crossref
Crossref
Sarah M. Drawz & Robert A. Bonomo. (2010) Three Decades of β-Lactamase Inhibitors. Clinical Microbiology Reviews 23:1, pages 160-201.
Crossref
Crossref
George M. Brenner & Craig W. Stevens. 2010. Pharmacology. Pharmacology
424
435
.
Karen Bush. 2010. Antibiotic and Chemotherapy. Antibiotic and Chemotherapy
226
244
.
HENRY F. CHAMBERS. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
309
322
.
Mao Mao An, Zui Zou, Hui Shen, Jun Dong Zhang, Meng Li Chen, Ping Liu, Rui Wang & Yuan Ying Jiang. (2009) Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials. BMC Infectious Diseases 9:1.
Crossref
Crossref
Katherine M Shea, S Christian Cheatham, David W Smith, Matthew F Wack, Kevin M Sowinski & Michael B Kays. (2009) Comparative Pharmacodynamics of Intermittent and Prolonged Infusions of Piperacillin/Tazobactam Using Monte Carlo Simulations and Steady-State Pharmacokinetic Data from Hospitalized Patients. Annals of Pharmacotherapy 43:11, pages 1747-1754.
Crossref
Crossref
Katherine M. Shea, S. Christian Cheatham, Matthew F. Wack, David W. Smith, Kevin M. Sowinski & Michael B. Kays. (2009) Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patients. International Journal of Antimicrobial Agents 34:5, pages 429-433.
Crossref
Crossref
É. Denes & N. Hidri. (2009) Synergie et antagonisme en antibiothérapie. Antibiotiques 11:2, pages 106-115.
Crossref
Crossref
Elisa Bertazzoni Minelli, Anna Benini, Luigina Franco, Claudio Bassi & Paolo Pederzoli. (2008) Piperacillin-Tazobactam Penetration into Human Pancreatic Juice. Antimicrobial Agents and Chemotherapy 52:11, pages 4149-4152.
Crossref
Crossref